Journal of Respiratory Diseases

Journal of Respiratory Diseases

Journal of Respiratory Diseases – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript

Aims & Scope

Journal of Respiratory Diseases (JRD) publishes mechanistic research elucidating the molecular and cellular pathophysiology of respiratory diseases, from biomarker discovery to disease pathway analysis.
Disease Mechanisms Molecular Pathways Biomarker Discovery Cellular Pathophysiology Disease Models

Core Research Domains

Inflammatory Lung Disease Mechanisms

  • Molecular pathways in asthma pathogenesis
  • COPD inflammatory cascade mechanisms
  • Cytokine signaling in chronic bronchitis
  • Epithelial-mesenchymal transition in airway remodeling
  • Oxidative stress pathways in lung inflammation
  • Immune cell dysfunction in bronchiectasis
Typical Fit Example "Identification of novel IL-17 signaling intermediates driving neutrophilic inflammation in severe asthma through single-cell RNA sequencing"

Fibrotic Disease Pathophysiology

  • Molecular mechanisms of idiopathic pulmonary fibrosis
  • Fibroblast activation pathways in lung scarring
  • Extracellular matrix remodeling mechanisms
  • TGF-β signaling in pulmonary fibrosis
  • Epithelial injury and repair mechanisms
  • Senescence pathways in fibrotic lung disease
Typical Fit Example "Characterization of myofibroblast differentiation pathways and identification of targetable kinases in progressive pulmonary fibrosis using proteomics"

Respiratory Infection Pathogenesis

  • Host-pathogen interaction mechanisms in pneumonia
  • Viral entry and replication pathways in respiratory epithelium
  • Innate immune response mechanisms to respiratory pathogens
  • Bacterial virulence factor mechanisms in lung infection
  • Immune evasion strategies of respiratory pathogens
  • Molecular basis of tuberculosis granuloma formation
Typical Fit Example "Mechanistic analysis of SARS-CoV-2 spike protein interaction with ACE2 receptor and downstream inflammatory signaling cascades in alveolar cells"

Pulmonary Vascular Pathobiology

  • Molecular mechanisms of pulmonary hypertension
  • Endothelial dysfunction pathways in vascular remodeling
  • Smooth muscle cell proliferation mechanisms
  • Hypoxia signaling in pulmonary vasculature
  • Thrombotic pathway activation in pulmonary embolism
  • Angiogenesis dysregulation in vascular lung diseases
Typical Fit Example "Identification of endothelin-1 signaling intermediates driving pulmonary arterial smooth muscle proliferation through phosphoproteomics analysis"

Secondary Focus Areas

Biomarker Discovery & Validation

Identification and mechanistic characterization of molecular biomarkers for respiratory disease diagnosis, prognosis, and mechanistic stratification. Focus on pathway-linked biomarkers with mechanistic rationale.

Disease Model Development

Development and characterization of in vitro, ex vivo, and animal models that recapitulate respiratory disease pathophysiology. Emphasis on mechanistic validation and translational relevance.

Occupational Lung Disease Mechanisms

Molecular pathways underlying silicosis, asbestosis, and hypersensitivity pneumonitis. Focus on particle-induced cellular responses, inflammation mechanisms, and fibrotic pathway activation.

Rare Lung Disease Pathophysiology

Mechanistic studies of sarcoidosis, lymphangioleiomyomatosis (LAM), and other rare interstitial lung diseases. Emphasis on unique molecular pathways and disease-specific mechanisms.

Sleep-Disordered Breathing Mechanisms

Molecular and cellular mechanisms underlying obstructive sleep apnea, including intermittent hypoxia signaling, inflammatory pathway activation, and cardiovascular consequences at the molecular level.

Lung Cancer Pathobiology

Molecular mechanisms of lung carcinogenesis, tumor microenvironment interactions, metastatic pathway activation, and resistance mechanisms. Focus on pathophysiological understanding rather than clinical oncology.

Emerging Research Frontiers

Selective Consideration with Enhanced Editorial Review

Single-Cell Omics in Lung Disease Mechanistic insights from single-cell transcriptomics, proteomics, and spatial profiling revealing cellular heterogeneity in respiratory pathophysiology.
Epigenetic Mechanisms DNA methylation, histone modifications, and non-coding RNA regulation in respiratory disease pathogenesis and progression.
Microbiome-Host Interactions Molecular mechanisms by which respiratory microbiome alterations influence lung disease pathophysiology through immune modulation and metabolic pathways.
Mitochondrial Dysfunction Mitochondrial pathway dysregulation, oxidative phosphorylation defects, and metabolic reprogramming in respiratory disease mechanisms.
Mechanobiology of Lung Disease Mechanical force sensing, mechanotransduction pathways, and biomechanical stress responses in respiratory pathophysiology.
AI-Driven Pathway Discovery Machine learning approaches for identifying novel disease mechanisms, pathway interactions, and molecular signatures from multi-omics datasets.
Note: Emerging area submissions undergo additional editorial assessment to ensure strong mechanistic focus and alignment with journal scope.

Article Types & Editorial Priorities

Priority 1 - Fast Track

Expedited Review (4-6 weeks)

Priority 2 - Standard

Regular Review (6-8 weeks)

Selective Consideration

Enhanced Editorial Assessment

Editorial Standards & Requirements

Reporting Guidelines

  • ARRIVE 2.0 for animal studies
  • MIQE for qPCR experiments
  • PRISMA for systematic reviews
  • STROBE for observational studies
  • CONSORT for clinical trials (if mechanistic)

Data Transparency

  • Raw data deposition in public repositories
  • Omics data in GEO, ArrayExpress, or ProteomeXchange
  • Code availability for computational analyses
  • Reagent and resource sharing statements
  • Reproducibility documentation required

Ethics & Integrity

  • IRB/Ethics committee approval for human samples
  • IACUC approval for animal studies
  • Informed consent documentation
  • Conflict of interest disclosure
  • Adherence to COPE guidelines

Preprint Policy

  • Preprint posting encouraged (bioRxiv, medRxiv)
  • Does not affect consideration for publication
  • Must be disclosed during submission
  • Version control maintained
  • Preprint DOI linked in final publication

Ready to Submit Your Research?

If your work elucidates molecular mechanisms of respiratory disease pathophysiology, we want to hear from you. Questions about scope fit? Contact our editorial team before submission.

Contact Editorial Office